VITAMIN D INSUFFICIENCY AND PROGNOSIS IN LYMPHOMA

EHA Library, Blanca Sanchez-Gonzalez, 266126

RECOMBINANT FACTOR VIII FC FUSION PROTEIN IN SURGERIES IN HEMOPHILIA A

EHA Library, Vinod Patil, 266127

PREDICTORS OF TREATMENT RESPONSE TO IMMUNOSUPPRESSANTS IN ACQUIRED HEMOPHILIA A

EHA Library, Wai Nga Grace Lau, 266128

INTRACRANIAL HEMORRHAGE IN IMMUNE THROMBOCYTOPENIA: A SINGLE-CENTRED STUDY OF 36 PATIENTS

EHA Library, Peng Zhao, 266129

MODE OF DELIVERY IN NEWBORNS WITH HEMOPHILIA: ASSOCIATION WITH FAMILY HISTORY/MATERNAL CARRIER STATUS, SEVERITY OF HEMOPHILIA AND INCIDENCE OF INTRACRANIAL/EXTRACRANIAL HEMORRHAGE

EHA Library, AIKATERINI MICHALOPOULOU, 266130

COST-EFFECTIVENESS OF EMICIZUMAB VERSUS BY-PASSING AGENTS IN PATIENTS WITH HAEMOPHILIA A AND FVIII INHIBITORS IN FRANCE

EHA Library, Benoit Polack, 266131

THE EFFECT OF ANTITHROMBOTIC STEWARDSHIP ON THE EFFICACY AND SAFETY OF ANTITHROMBOTIC THERAPY DURING AND AFTER HOSPITALIZATION IN TWO DUTCH HOSPITALS

EHA Library, Albert Dreijer, 266132

RISK OF BLEEDING COMPLICATIONS AND ATRIAL FIBRILLATION ASSOCIATED WITH IBRUTINIB TREATMENT: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Luca Pellegrini, 266133

EPIDURAL/SPINAL ANESTHESIA IN PREGNANT JEWISH ASHKENAZI WOMEN HETEROZYGOTES FOR FACTOR XI DEFICIENCY, A SINGLE CENTER PROSPECTIVE STUDY

EHA Library, Adi Abulafia, 266134

MUTATION SPECTRUM OF F8 GENE IN HEMOPHILIA A PATIENTS FROM RUSSIA

EHA Library, Olesya Pshenichnikova, 266135

EVALUATION OF THROMBOPOIETIN-RECEPTOR AGONISTS (TPO-RAS) «STOP-THERAPY» IN IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)

EHA Library, Maria Pankrashkina, 266136

ALRN-6924, A DUAL INHIBITOR OF MDMX AND MDM2 THAT CAUSES MINIMAL THROMBOCYTOPENIA IN PATIENTS, DISRUPTS DIFFERENT STAGES OF THROMBOPOIESIS COMPARED TO MDM2-ONLY INHIBITION

EHA Library, Allen Annis, 266137

DEVELOPMENT AND OPTIMISATION OF A FULLY HUMAN FVIII MIMETIC BISPECIFIC ANTIBODY FOR PATIENTS WITH HAEMOPHILIA A

EHA Library, Wei Wang, 266138

BIOLOGICAL AND CLINICAL FACTORS THAT FAVOR THE USE OF A SPECIFIC TPO-RA IN ITP PATIENTS. RESULTS FROM A SPANISH MULTICENTER STUDY

EHA Library, María Lozano, 266139

PATIENTS WITH HIGHER BODY MASS INDEX TREATED WITH DIRECT / NON VITAMIN K DEPENDENT ANTICOAGULANTS (DOAC / NOAC) EXPERIENCE WORSE CLINICAL OUTCOMES

EHA Library, Marko Lucijanic, 266140

LUSUTROMBOPAG FOR TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC LIVER DISEASE WHO ARE UNDERGOING PLANNED INVASIVE PROCEDURES: POOLED SAFETY ANALYSIS OF BLEEDING-RELATED ADVERSE EVENTS

EHA Library, Edoardo G. Giannini, 266141

COMPENSATORY MUTATIONS IN PROMOTERS OF TELOMERASE GENES ARE RARE IN TELOMERE BIOLOGY DISORDERS WITH BONE MARROW FAILURE.

EHA Library, Rebecca Voss, 266142

CRISPR/CAS9 MEDIATED ELANE KNOCKOUT ENABLES NEUTROPHILIC MATURATION OF HSPCS AND IPSCS OF SEVERE CONGENITAL NEUTROPENIA PATIENTS

EHA Library, Julia Skokowa, 266143

HIGH FREQUENCY ASXL1 MUTATIONS AND MULTIPLE SUBCLONAL PIGA MUTATIONS ARE OBSERVED IN CELLULAR AND CELL-FREE DNA IN PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA

EHA Library, Georgie Ryland, 266144

THE INVOLVEMENT OF OXIDATIVE STRESS, INFLAMMATION, AND DNA DAMAGE RESPONSE IN PATHOPHYSIOLOGY OF DIAMOND-BLACKFAN ANEMIA

EHA Library, Katarina Kapralova, 266145

ZEBRAFISH AS A NOVEL MODEL TO STUDY GATA2 HAPLOINSUFFICIENCY SYNDROMES

EHA Library, Emanuele gioacchino, 266146

PHARMACOKINETIC AND PHARMACODYNAMIC SIMILARITY OF ABP 959 WITH ECULIZUMAB: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, SINGLE-DOSE, PARALLEL-GROUP STUDY IN HEALTHY SUBJECTS

EHA Library, Vincent Chow, 266147

LONG TERM FOLLOW-UP OF PNH PATIENTS TREATED WITH THE SMART ANTI-HC5 ANTIBODY (SKY59/RO7112689) IN THE OPEN LABEL EXTENSION (OLE) OF THE COMPOSER TRIAL

EHA Library, Alexander Röth, 266148

57 PATIENTS WITH HAX1 ASSOCIATED CONGENITAL NEUTROPENIA: AN ANALYSIS OF THE EUROPEAN SEVERE CHRONIC NEUTROPENIA INTERNATIONAL REGISTRY (SCNIR)

EHA Library, Cornelia Zeidler, 266149

CONSTRUCTION OF A PROGNOSTIC MODEL FOR HLH IN ADULTS - ANALYSIS FROM THE PALG HLH IN ADULTS DATABASE

EHA Library, Rafal Machowicz, 266150

ALPS DISEASE AND ALPS PHENOTYPE: DISTINCT ENTITIES ?

EHA Library, Francesca Fioredda, 266151

TUNISIAN FANCONI ANEMIA REGISTRY (TFAR) REPORT, THE 2018 UPDATE

EHA Library, sondes Hadiji Mseddi, 266152

PATIENTS WITH SEVERE CHRONIC NEUTROPENIA SUBTYPES TREATED WITH BIOSIMILAR FILGRASTIM: A STUDY BY THE EUROPEAN BRANCH OF THE SEVERE CHRONIC NEUTROPENIA INTERNATIONAL REGISTRY

EHA Library, Cornelia Zeidler, 266153

HOW TELOMERE LENGTH SCREENING CAN BE HELPFUL FOR THE DIAGNOSIS OF CYTOPENIC PATIENTS?

EHA Library, Filomena Pierri, 266154

INTEGRATION OF GENOMIC AND EPIGENOMIC DATA REFINES THE REGULATORY MECHANISMS AND BIOLOGICAL SIGNIFICANCE OF CHRONIC LYMPHOCYTIC LEUKEMIA RISK LOCI

EHA Library, Renée Beekman, 266155

CHRONIC LYMPHOCYTIC LEUKEMIA INDUCES SKEWING OF (ANTIGEN-SPECIFIC) T CELL RESPONSES TOWARDS A DYSFUNCTIONAL SHORT-LIVED EFFECTOR PHENOTYPE

EHA Library, Anne Martens, 266156

A NOVEL REFINED PROGNOSTIC MODEL FOR CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS COMBINING IGH TRANSLOCATIONS AND NEXT-GENERATION SEQUENCING

EHA Library, Claudia Perez-Carretero, 266157

FUNCTIONAL HIERARCHY AMONG PRO-SURVIVAL BCL-2 MEMBERS IN DETERMINING RESISTANCE TO VENETOCLAX IN CLL

EHA Library, Marco Haselager, 266158

TP53 CLONAL AND SUBCLONAL ARCHITECTURE IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS UNDER IBRUTINIB TREATMENT

EHA Library, Luciana Cafforio, 266159

IN-VITRO DRUG SENSITIVITY SCREENING IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENT SAMPLES IDENTIFIES DRUG CANDIDATES FOR PRECISION CANCER THERAPY

EHA Library, Sigrid S. Skånland, 266160

ATR-CHK1 SIGNALING IS ACTIVE AND TARGETABLE IN QUIESCENT CLL CELLS

EHA Library, Miroslav Boudny, 266161

A FIRST HIGH-DEFINITION LANDSCAPE OF SOMATIC MUTATIONS IN CHRONIC LYMPHOPROLIFERATIVE DISORDER OF NK CELLS

EHA Library, Vanessa Rebecca Gasparini, 266162

UNDETECTABLE EXPRESSION OF WNT5A, A GENE ENCODING A ROR1 LIGAND, DEFINES MEMORY B-CELL LIKE CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Lucie Poppova, 266163

BORTEZOMIB LOWERS THE STAT3 PATHOGENETIC ROLE IN T-LGLL NEUTROPENIA DEVELOPMENT BY RESTORING MIR146B EXPRESSION

EHA Library, Giulia Calabretto, 266164

PROGNOSTIC IMPLICATIONS OF IGHV GENE REARRANGEMENTS WITH “BORDERLINE” PERCENTAGE OF MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

EHA Library, Sara Raponi, 266165

CXCR5+PD-1+ CD8+ T-CELLS IN HUMAN BLOOD AND LYMPH NODES

EHA Library, Tom Hofland, 266166

MOLECULAR EVIDENCE THAT ATOVAQUONE IS A NEW STAT3-INHIBITOR COUNTERBALANCING LEUKEMIC CELL PRO-SURVIVAL IN LARGE GRANULAR LYMPHOCYTE LEUKEMIA

EHA Library, Antonella Teramo, 266167

DYSREGULATION OF BACH2 AND FOXP1 GENES IN T AND B CELLS IS MORE PRONOUNCED IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS COMPARED TO AGED-MATCHED HEALTHY DONORS WITH AN IMPACT ON SURVIVAL

EHA Library, Dominique BRON, 266168

EXPLOITING IRON TOXICITY TO INCREASE VULNERABILITY OF MALIGNANT B CELLS

EHA Library, Jessica Bordini, 266169

SIGNAL-OMICS ANALYSIS OF THE IMPACT OF THERAPY ON BCR SIGNALLING IN CHRONIC LYMPHOCYTIC LEUKAEMIA.

EHA Library, Adam Linley, 266170

DNA METHYLTRANSFERASES GENE EXPRESSION LEVELS IN CHRONIC LYMPHOCYTIC LEUKEMIA - IMPACT IN DEVELOPMENT, DIAGNOSIS AND PROGNOSIS

EHA Library, Ana Bela Sarmento-Ribeiro, 266171

INHIBITION OF BROMODOMAIN AND EXTRA-TERMINAL (BET) PROTEINS INCREASES SENSITIVITY TO VENETOCLAX IN CHRONIC LYMPHOCYTIC LEUKEMIA.

EHA Library, Giovanna carrà, 266172

IMPACT OF ATM ALTERATIONS ON CHRONIC LYMPHOCYTIC LEUKEMIA IN GENERAL PRACTICE IN THE AREA OF NEXT GENERATION SEQUENCING

EHA Library, Sophie De Guibert, 266173

IBRUTINIB PLUS FLUDARABINE, CYCLOPHOSPHAMIDE, AND RITUXIMAB (IFCR) AS INITIAL THERAPY FOR YOUNGER PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A SINGLE-ARM, MULTICENTER, PHASE 2 TRIAL

EHA Library, Matthew Davids, 266174

IBRUTINIB AND RITUXIMAB AS FRONT-LINE TREATMENT FOR UNFIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL). PRELIMINARY RESULTS FROM THE GIMEMA LLC1114 STUDY.

EHA Library, Francesca Romana Mauro, 266175

DIFFERENTIAL GENOMIC AND TRANSCRIPTOMIC EVENTS ASSOCIATED WITH HIGH-GRADE TRANSFORMATION OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Jenny Klintman, 266176

ACALABRUTINIB WITH OBINUTUZUMAB IN TREATMENT-NAIVE AND RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: 3-YEAR FOLLOW-UP

EHA Library, Jennifer Woyach, 266177

TREATMENT EMERGENT ADVERSE EVENTS VARY WITH DIFFERENT PI3K INHIBITORS

EHA Library, Farrukh Awan, 266178

PREVALENCE AND INCIDENCE OF CARDIOVASCULAR DISEASE IN CHRONIC LYMPHOCYTIC LEUKEMIA: A NATION-WIDE POPULATION-BASED STUDY.

EHA Library, Karin Larsson, 266179

SINGLE CELL ABNORMALITIES ON CLASSIC G-BANDING ANALYSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA: CLINICOBIOLOGICAL FEATURES AND PROGNOSTIC VALUE

EHA Library, Anastasia Athanasiadou, 266180

FACTORS IMPACTING TREATMENT SELECTION IN TREATMENT-NAÏVE PATIENTS WITH CLL: A MULTICENTER STUDY

EHA Library, Joanna Rhodes, 266181

PROGNOSTIC MODELS FOR CHRONIC LYMPHOCYTIC LEUKEMIA: AN EXEMPLAR SYSTEMATIC COCHRANE REVIEW AND META-ANALYSIS (PRELIMINARY RESULTS)

EHA Library, Nina Kreuzberger, 266182

PROGNOSTIC TESTING AND TREATMENT APPROACHES BASED ON REAL-WORLD CLINICAL EXPERIENCE FROM AN INTERIM ANALYSIS OF THE INFORMCLL REGISTRY OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Anthony R. Mato, 266183

EFFECTIVENESS AND SAFETY OF IBRUTINIB FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN ROUTINE CLINICAL PRACTICE: INTERIM ANALYSIS (IA) OF THE BELGIAN IBRUTINIB REAL-WORLD DATA (BIRD) STUDY

EHA Library, Ann Janssens, 266184

ANTICOAGULATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATED WITH IBRUTINIB

EHA Library, William Archibald, 266185

HYPERTENSION IN PATIENTS TREATED WITH IBRUTINIB FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Lindsey Roeker, 266186

FRENCH IBRUTINIB OBSERVATIONAL STUDY (FIRE): REAL-WORLD STUDY OF IBRUTINIB TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN FRANCE

EHA Library, Caroline Dartigeas, 266187

HAT-PCR IS MORE SENSITIVE THAN FLOW FOR QUANTIFYING MRD IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Alexander Morley, 266188

PROGRESSION-FREE SURVIVAL PREDICTS OVERALL SURVIVAL IN FRONTLINE CLL

EHA Library, simona baculea, 266189

FIRST-LINE TREATMENT WITH LENALIDOMIDE DOES IMPROVE OUTCOME IN ELDERLY/UNFIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Julia Driessen, 266190

INFLUENCE OF ATORVASTATIN THERAPY ON GALECTIN-3, VE-CADHERIN, AND CARDIOVASCULAR RISK IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Borys Samura, 266191

MONOCLONAL GAMMOPATHY AND HYPOGAMMAGLOBULINEMIA AS INDEPENDENT PROGNOSTIC FACTORS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A RETROSPECTIVE MULTICENTRIC EXPERIENCE.

EHA Library, Andrea Corbingi, 266192

A RANDOMISED JOINT AUSTRALASIAN (ALLG) AND FRENCH (FILO) STUDY OF LENALIDOMIDE CONSOLIDATION IN PATIENTS WITH RESIDUAL CLL AFTER FRONT-LINE TREATMENT WITH FC/FCR (THE CLL6 TRIAL)

EHA Library, David Gottlieb, 266193

RHYTHM AND CONDUCTION DISORDERS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING TREATMENT WITH IBRUTINIB.

EHA Library, Elena Emelina, 266194

COMPLEX EVALUATION OF CELLULAR AND HUMORAL IMMUNITY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Lukáš Smolej, 266195

HISTONE DEACETYLASE INHIBITOR PANOBINOSTAT TARGETS CALCINEURIN/NFATC1 SIGNALING AND ABROGATES THE RESISTANCE OF PH+ LEUKEMIA CELLS TO DASATINIB

EHA Library, Katia Beider, 266196

IDENTIFICATION OF PROTEIN-PROTEIN INTERACTIONS NECESSARY FOR MAINTENANCE OF BCR-ABL CORE COMPLEX

EHA Library, Tomas Gregor, 266197

KNOCKDOWN OF LASP1 IN CXCR4 EXPRESSING CML CELLS PROMOTES CELL PERSISTENCE, PROLIFERATION AND TKI RESISTANCE

EHA Library, Andreas B Herrmann, 266198

GENE EXPRESSION PROFILING OF CD26+ LEUKEMIC STEM CELL POPULATION FROM CML PATIENTS

EHA Library, Dagmar Smitalová, 266199

ANTI-LEUKEMIA EFFECT OF DISULFIRAM AND ASCORBATE IN ABL TYROSINE KINASE INHIBITOR RESISTANT LEUKEMIA CELLS

EHA Library, Seiichi Okabe, 266200

IMMUNE SYSTEM AND CHRONIC MYELOID LEUKEMIA: THE IMPACT OF TYROSINE KINASE INHIBITORS

EHA Library, Ana Bela Sarmento-Ribeiro, 266201

PECULIARITIES OF THE EXPRESSION OF KI-67 AND CD34 HEMOPOIETIC PRECURSOR CELLS IN PB AND BM OF CML PATIENTS WITH THE DIFFERENT RESPONSES TO IMATINIB AND NILOTINIB THERAPY

EHA Library, Tetiana Perekhrestenko, 266202

NEGATIVE MR4.0 CHRONIC MYELOID LEUKEMIA AND ITS IMPLICATIONS FOR TREATMENT-FREE REMISSION

EHA Library, Nuno Cerveira, 266203

TUMOR-DERIVED EXOSOMES MAY BE USED AS NEW INFORMATIVE TOOL FOR THE DETECTION OF BONE MARROW RESIDUAL CML LEUKEMIC CELLS ACTIVITY

EHA Library, Simona Bernardi, 266204

DASCERN 2-YEAR EXTENDED FOLLOW-UP OF DASATINIB EFFICACY AND SAFETY IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) WHO HAVE SUBOPTIMAL RESPONSES TO 3 MONTHS OF IMATINIB

EHA Library, Giuseppe Saglio, 266205

PRIMARY THERAPY AND RELATIVE SURVIVAL AMONG ELDERLY PATIENTS WITH CHRONIC MYELOID LEUKEMIA: A POPULATION-BASED STUDY IN THE NETHERLANDS, 1989-2016.

EHA Library, Geneviève Ector, 266206

TREATMENT-FREE REMISSION IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA FOLLOWING FIRST-LINE DASATINIB, 1ST DADI/IMIDAS4

EHA Library, KAZUNORI MURAI, 266207

DASFREE 2-YEAR UPDATE: DASATINIB DISCONTINUATION IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) AND DEEP MOLECULAR RESPONSE (DMR)

EHA Library, Michael J. Mauro, 266208

DURABILITY AND IMPACT ON QUALITY OF LIFE OF TREATMENT-FREE REMISSION (TFR) IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) AFTER STOPPING FRONTLINE (1L) NILOTINIB: ENESTFREEDOM 192-WK RESULTS

EHA Library, David Ross, 266209

DOUBLING TIME AFTER FIRST ATTEMPT OF IMATINIB DISCONTINUATION IS HELPFUL TO IDENTIFY THE BEST CANDIDATE FOR THE SECOND ATTEMPT FOR TREATMENT-FREE REMISSION WITH DASATINIB: CANADIAN TRAD TRIAL

EHA Library, Dennis Kim, 266210

ENESTOP 192-WK RESULTS: DURABILITY AND IMPACT ON QUALITY OF LIFE OF TREATMENT-FREE REMISSION (TFR) FOLLOWING SECOND-LINE (2L) NILOTINIB (NIL) IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA (CML)

EHA Library, François-Xavier Mahon, 266211

A PHASE 2 STUDY OF NILOTINIB (NIL) IN PEDIATRIC PATIENTS (PTS) WITH PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID LEUKEMIA (CML): SAFETY UPDATE AFTER 36 CYCLES OF TREATMENT

EHA Library, Nobuko Hijiya, 266212

CARDIAC, VASCULAR, AND HYPERTENSION SAFETY OF BOSUTINIB VS IMATINIB FOR NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA IN THE BFORE TRIAL

EHA Library, Tim H Brümmendorf, 266213

DNA-BASED BCR-ABL1 ANALYSIS PROVIDES A “TRAFFIC LIGHT” STRATIFICATION MODEL FOR CHRONIC MYELOID LEUKEMIA WITH IMPLICATIONS FOR TREATMENT FREE REMISSION

EHA Library, Katerina Machova Polakova, 266214

EFFICACY AND SAFETY FOLLOWING DOSE REDUCTION OF BOSUTINIB IN PREVIOUSLY TREATED PATIENTS WITH CHRONIC MYELOID LEUKEMIA: ANALYSIS OF THE PHASE 4 BYOND TRIAL

EHA Library, Tim H Brümmendorf, 266215

GROWTH RATE AND ENDOCRINE EFFECTS OF DASATINIB THERAPY OBSERVED IN A RETROSPECTIVE ANALYSIS OF A PHASE 2 CLINICAL TRIAL FOR PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP)

EHA Library, Briana Patterson, 266216

PONATINIB IN CHILDHOOD PHILADELPHIA POSITIVE LEUKEMIAS: THE EXPERIENCE OF THE INTERNATIONAL REGISTRY OF CHILDHOOD CHRONIC MYLELOID LEUKEMIA (I-CML-PED-STUDY).

EHA Library, Frederic MILLOT, 266217

TREATMENT-FREE REMISSION IN REAL-WORLD CHRONIC MYELOID LEUKEMIA PATIENTS: INSIGHTS FROM GERMAN CLINICAL HEMATOLOGY PRACTICES

EHA Library, Alexander Kiani, 266218

ANALYSIS OF THE INFLUENCE OF AGE ON MAJOR MOLECULAR RESPONSE,DEEP MOLECULAR RESPONSE AND SURVIVAL OUTCOMES IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS (TKIS).

EHA Library, Luis Felipe Casado Montero, 266219

RESULTS OF A PROSPECTIVE MULTICENTER STUDY ON PRO-ATHEROTHROMBOTIC EFFECT INDUCED BY TYROSINE-KINASE INHIBITORS FOR FIRST-LINE TREATMENT OF CML PTS (KIARO TRIAL)

EHA Library, Anna Sicuranza, 266220

PLANNED PREGNANCY IN FEMALE PATIENTS WITH CHRONIC MYELOID LEUKEMIA RECEIVING TYROSINE KINASE INHIBITOR THERAPY

EHA Library, Qian Jiang, 266221

THE LONG-TERM TREATMENT RESULTS OF THE MULTICENTER EUTOS ELN POPULATION-BASED STUDY (EUTOS-PBS) IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN RUSSIAN FEDERATION

EHA Library, Olga Lazareva, 266222

SAFETY OF IMATINIB AND ITS GENERICS IN CHRONIC MYELOID LEUKEMIA: A SUBANALYSIS OF POLISH IMATINIB GENERICS REGISTRY AFTER THREE YEARS OF OBSERVATION

EHA Library, Joanna Wącław, 266223

DISTINCT CYTOKINE PROFILES CHARACTERISE CML PATIENTS WHO HAVE HIGHER RISK OF EMR FAILURE AND BLAST CRISIS PROGRESSION

EHA Library, Liu Lu, 266224

PIEZO1 MEDIATED CALCIUM-INDUCED SIGNAL TRANSDUCTION IN ERYTHROBLASTS MODULATES ERYTHROPOIESIS

EHA Library, Francesca Aglialoro, 266225